Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
BioPharma
Stay updated with breaking news from Art Krieg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, Sept. 04, 2022 (GLOBE NEWSWIRE) -- OTS is pleased to announce that, after two years of meeting virtually, the 18th Annual Oligo Meeting will...
Investegate announcements from Oligonucleotide Therapeutics S, The Oligonucleotide Therapeutics Society's Highly Anticipated Annual Meeting Returns in Person This Year
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biopharmaceutical company focused on proprietary technology to harness the power of the immune system to combat cancer, today announced a definitive agreement for the acquisition of Checkmate by ...
Regeneron is moving to make an all-cash acquisition of Checkmate Pharmaceuticals worth...